Charles Hugh-Jones

Directeur Technique/Scientifique/R&D chez FRESENIUS MEDICAL CARE AG

56 ans

Health Technology

Health Services

Profil

Charles Hugh-Jones is the Global Chief Medical Officer at Fresenius Medical Care AG, starting in 2026.
Formerly, Dr. Hugh-Jones was Chief Executive Officer at Volastra Therapeutics, Inc., Chief Medical Officer at Allergan UC from 2018 to 2020, and worked at Addleshaw Booth & Co. from 2004 to 2007.

Postes actifs de Charles Hugh-Jones

Sociétés	Poste	Début
FRESENIUS MEDICAL CARE AG	Directeur Technique/Scientifique/R&D	01/01/2026

Tous les postes actifs de Charles Hugh-Jones

Anciens postes connus de Charles Hugh-Jones

Sociétés	Poste	Fin
Volastra Therapeutics, Inc. Volastra Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in discovery and development of oncology therapeutics	Directeur Général	27/05/2025
ALLERGAN PLC	Directeur Technique/Scientifique/R&D	08/05/2020

Voir l'expérience en détail de Charles Hugh-Jones

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Charles Hugh-Jones

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	3
Fresenius Medical Care AG Fresenius Medical Care AG Medical/Nursing ServicesHealth Services Manufactures and supplies renal and dialysis products	Health Services
Allergan Ltd. (Ireland) Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes pharmaceuticals, devices, biological, surgical & regenerative medicine products	Health Technology
Volastra Therapeutics, Inc. Volastra Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in discovery and development of oncology therapeutics	Health Technology